We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$948M
AUM Growth
+$41M
Cap. Flow
+$12.7M
Cap. Flow %
1.34%
Top 10 Hldgs %
27.51%
Holding
266
New
20
Increased
64
Reduced
83
Closed
5

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$8.88M
2
WAB icon
Wabtec
WAB
+$4.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$2.26M
4
JPM icon
JPMorgan Chase
JPM
+$1.62M
5
XLRN
Acceleron Pharma
XLRN
+$1.57M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$6.45M
2
WFC icon
Wells Fargo
WFC
+$1.74M
3
HSIC icon
Henry Schein
HSIC
+$1.42M
4
UPS icon
United Parcel Service
UPS
+$1.09M
5
CB icon
Chubb
CB
+$910K

Sector Composition

Rank Sector Weight
1 Healthcare 16.99%
2 Industrials 14.77%
3 Financials 14.58%
4 Technology 13.43%
5 Energy 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
76
UnitedHealth
UNH
$370B
$3.35M 0.35%
13,667
+526
+4% +$126K
PSX icon
77
Phillips 66
PSX
$81.4B
$3.31M 0.35%
29,509
-700
-2% -$78.7K
COP icon
78
ConocoPhillips
COP
$141B
$3.22M 0.34%
46,232
-1,450
-3% -$96.6K
RIO icon
79
Rio Tinto
RIO
$164B
$3.17M 0.33%
57,100
+8,000
+16% +$448K
HUBB icon
80
Hubbell
HUBB
$27.2B
$3.15M 0.33%
29,798
-3,000
-9% -$332K
CAT icon
81
Caterpillar
CAT
$387B
$3.1M 0.33%
22,868
+750
+3% +$112K
BKU icon
82
Bankunited
BKU
$3.36B
$2.99M 0.32%
73,249
+432
+0.6% +$17.9K
AME icon
83
Ametek
AME
$58.2B
$2.97M 0.31%
41,139
-1,616
-4% -$120K
GILD icon
84
Gilead Sciences
GILD
$165B
$2.91M 0.31%
41,053
+374
+0.9% +$26.4K
AMZN icon
85
Amazon
AMZN
$2.96T
$2.76M 0.29%
32,480
+7,540
+30% +$598K
DVN icon
86
Devon Energy
DVN
$47.3B
$2.61M 0.28%
59,299
+600
+1% +$23.2K
SPGI icon
87
S&P Global
SPGI
$120B
$2.6M 0.27%
12,750
– –
BAX icon
88
Baxter International
BAX
$14.2B
$2.51M 0.27%
34,050
– –
BAC icon
89
Bank of America
BAC
$442B
$2.47M 0.26%
87,671
+20,304
+30% +$606K
BNY
90
Bank of New York Mellon
BNY
$107B
$2.41M 0.25%
44,682
-200
-0.4% -$11K
TXN icon
91
Texas Instruments
TXN
$261B
$2.28M 0.24%
20,675
+600
+3% +$64.9K
GS icon
92
Goldman Sachs
GS
$303B
$2.26M 0.24%
10,265
+370
+4% +$88.2K
ESRX
93
DELISTED
Express Scripts Holding Company
ESRX
$2.14M 0.23%
27,699
+1,600
+6% +$120K
XLRN
94
DELISTED
Acceleron Pharma
XLRN
$2.08M 0.22%
+42,964
New +$1.57M
HSIC icon
95
Henry Schein
HSIC
$9.82B
$1.97M 0.21%
34,495
-25,148
-42% -$1.42M
MOG.A icon
96
Moog Inc Class A
MOG.A
$12.8B
$1.71M 0.18%
21,887
– –
APC
97
DELISTED
Anadarko Petroleum
APC
$1.68M 0.18%
22,975
+600
+3% +$40.7K
MDT icon
98
Medtronic
MDT
$112B
$1.67M 0.18%
19,544
+641
+3% +$53.5K
MNR
99
DELISTED
Monmouth Real Estate Investment Corp
MNR
$1.65M 0.17%
100,000
– –
KMB icon
100
Kimberly-Clark
KMB
$36.5B
$1.65M 0.17%
15,660
-100
-0.6% -$10.4K
2 3
4
5 6

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2018 Portfolio in Review

As of Q2 2018, Neville Rodie & Shaw held 266 positions worth $948M, up 4.5% from $907M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Neville Rodie & Shaw's Q2 2018 filing shows 20 new, 64 increased, 83 reduced and 5 closed positions. Its largest new stake was Acceleron Pharma: 42,964 shares worth $2.08M. The largest sale was Invesco QQQ Trust, an estimated $6.45M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.

  • Neville Rodie & Shaw's largest Q2 2018 buy was Acceleron Pharma: 42,964 shares worth $2.08M.
  • Neville Rodie & Shaw added most to Allergan plc in Q2 2018, an estimated $8.88M increase.
  • Neville Rodie & Shaw's biggest Q2 2018 reduction was Wells Fargo, cutting an estimated $1.74M.
  • Neville Rodie & Shaw fully exited Invesco QQQ Trust in Q2 2018, selling an estimated $6.45M.
  • Neville Rodie & Shaw's ten largest holdings make up 28% of its $948M portfolio in Q2 2018.
  • Neville Rodie & Shaw opened 20 new positions and closed 5 in Q2 2018.
  • Neville Rodie & Shaw's portfolio value rose 4.5% quarter-over-quarter to $948M.

Based on Neville Rodie & Shaw's 13F filing for Q2 2018, filed 3 Jul 2018.